Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tablets

The company has received the final approval from the United States
Food & Drug Administration (USFDA) for its abbreviated new drug
application (ANDA) for Deferasirox tablets in the strength of 180 mg,
Alembic Pharmaceuticals said in a BSE filing.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-generic-chronic-iron-overload-treatment-tablets/articleshow/76401337.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny